ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
A major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
Geopolitical headlines push crypto traders toward nonstop venues. This piece explains why hyperliquid's token rises w...
VanEck’s latest assessment puts XRPL ahead of JPMorgan, Coinbase, and Canton Network. The ranking feeds the ongoing p...
XRPL adoption is expanding with tokenized funds and stablecoins on the ledger. The focus remains on XRP as it faces b...
XRP has repeatedly rebounded despite jitters in the crypto space. This article uncovers the real reason keeps bouncin...
When a stock leads the market after a big index move, investors pay attention. This piece explains why Argan stock to...
Bitcoin traded under $68,000 as a wave of liquidations hit the market, pushing the total to just over $1 billion. Mor...
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Investors are buzzing about whether strategy's peers will dump Bitcoin in a downturn. Analysts argue that headlines m...
A major fund manager parked 1.3 million shares in a leading self-storage REIT, signaling confidence in the sector. Ex...
A billionaire-backed fund is quietly accumulating Robinhood stock even as executives unload shares, a move prompting ...